2018 Annual Report

RNS Number : 7366Z

Dechra Pharmaceuticals PLC

04 September 2018

 

4 September 2018

Dechra^® Pharmaceuticals PLC

(Dechra or the Company)

Availability of 2018 Annual Report and Accounts

The 2018 Annual Report and Accounts is now available to view at www.dechra.com.

The following documents are scheduled to be mailed to registered shareholders of the Company on 17 September 2018:

·      2018 Annual Report and Accounts

·      Notice of the 2018 Annual General Meeting; and

·      Proxy Form for the 2018 Annual General Meeting.

In accordance with Listing Rule 9.6.1 a copy of each of these documents will be submitted to the National Storage Mechanism and will be available for viewing shortly after posting.

For further information, please contact:

Melanie Hall

Company Secretary

Telephone: [phone]

e-mail: [e-mail]

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Trademarks appear throughout this document in italics. Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

ACSLLFIFAFISIIT